コンテンツへスキップ
Merck

GF58573648

ルテチウム

powder, 1g, max. particle size 500 micron, 99.9%

別名:

ルテチウム

ログイン組織・契約価格を表示する


About This Item

実験式(ヒル表記法):
Lu
CAS番号:
分子量:
174.97
MDL番号:
UNSPSCコード:
11101711
PubChem Substance ID:
NACRES:
NA.23

アッセイ

99.9%

形状

powder

メーカー/製品名

Goodfellow 585-736-48

抵抗性

54 μΩ-cm, 20°C

粒径

500 μm

bp

3402 °C (lit.)

mp

1663 °C (lit.)

密度

9.84 g/mL at 25 °C (lit.)

SMILES記法

[Lu]

InChI

1S/Lu

InChI Key

OHSVLFRHMCKCQY-UHFFFAOYSA-N

類似した製品をお探しですか? 訪問 製品比較ガイド

詳細

For updated SDS information please visit www.goodfellow.com.

法的情報

Goodfellow製品

ピクトグラム

Flame

シグナルワード

Danger

危険有害性情報

危険有害性の分類

Flam. Sol. 1

保管分類コード

4.1B - Flammable solid hazardous materials

WGK

WGK 3

引火点(°F)

Not applicable

引火点(℃)

Not applicable


試験成績書(COA)

製品のロット番号・バッチ番号を入力して、試験成績書(COA) を検索できます。ロット番号・バッチ番号は、製品ラベルに「Lot」または「Batch」に続いて記載されています。

以前この製品を購入いただいたことがある場合

文書ライブラリで、最近購入した製品の文書を検索できます。

文書ライブラリにアクセスする

S Panigone et al.
The quarterly journal of nuclear medicine and molecular imaging : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), [and] Section of the Society of..., 50(4), 310-321 (2006-10-18)
Optimization of therapy for individual patients remains a goal of clinical practice. Radionuclide imaging can identify those patients who may benefit from subsequent targeted therapy by providing regional information on the distribution of the target. An ideal situation may be
R O Perez et al.
Techniques in coloproctology, 18(8), 699-708 (2014-02-11)
Molecular imaging using positron emission tomography/computerized tomography (PET/CT) may add relevant incremental diagnostic information to standard structural cross-sectional imaging. Such information may allow identification of patients with rectal cancer that are more likely to develop complete tumor regression after neoadjuvant
Alin Chirindel et al.
AJR. American journal of roentgenology, 204(5), 1093-1099 (2015-04-24)
The purpose of this study is to evaluate the performance of PET-derived parameters as prognostic markers for overall survival (OS) and progression-free survival (PFS) outcome in patients with pancreatic adenocarcinoma. We conducted a retrospective study of 106 patients (62 men
B L R Kam et al.
European journal of nuclear medicine and molecular imaging, 39 Suppl 1, S103-S112 (2012-03-06)
Treatment with radiolabelled somatostatin analogues is a promising new tool in the management of patients with inoperable or metastasized neuroendocrine tumours. Symptomatic improvement may occur with (177)Lu-labelled somatostatin analogues that have been used for peptide receptor radionuclide therapy (PRRT). The
Vijay Kumar Ichpujani et al.
Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons, 72(11), 2319-2332 (2014-12-02)
The fusion imaging modality of positron-emission tomography-computed tomography (PET-CT) has emerged as an important modality in the management of recurrent head and neck tumors. The aims of this study were to assess the role of PET-CT in the detection of

ライフサイエンス、有機合成、材料科学、クロマトグラフィー、分析など、あらゆる分野の研究に経験のあるメンバーがおります。.

製品に関するお問い合わせはこちら(テクニカルサービス)